If You Invested $1000 In Cogent Biosciences Stock 5 Years Ago, You Would Have This Much Todaybenzinga_article·Oct 21, 2026 at 04:45 PMCOGT-0.32%
Biotech Breakthroughs and Structural Invisibility: The Micro-Cap ParadoxGlobal Report·Oct 21, 2026 at 10:14 AMCOGT-0.32%ATTT-1.65%
Here’s How Much You Would Have Made Owning Cogent Biosciences Stock In The Last 5 Yearsbenzinga_article·Oct 12, 2026 at 10:45 PMCOGT-0.32%
$1000 Invested In Cogent Biosciences 5 Years Ago Would Be Worth This Much Todaybenzinga_article·Oct 2, 2026 at 09:48 PMCOGT-0.32%
Should FDA Filing Acceptance Require Action From Cogent Biosciences Stock Investors?Simplywall·Sep 18, 2026 at 05:59 AMCOGT-0.32%
Here’s How Much You Would Have Made Owning Merck & Co Stock In The Last 5 Yearsbenzinga_article·Sep 16, 2026 at 04:17 PMMRK-1.34%
Wedbush reiterates Outperform rating on Cogent Biosciences, $55 price targetTradingView·Sep 16, 2026 at 12:22 PMCOGT-0.32%
Cogent Biosciences (NASDAQ:COGT) Receives Buy Rating from HC WainwrightMarket Beat·Sep 15, 2026 at 02:06 PMCOGT-0.32%BLK-1.67%
Cogent Biosciences Secures Long-Term Bezuclastinib Supply DealTip Ranks·Sep 2, 2026 at 10:14 PMCOGT-0.32%
Cogent Biosciences signs Hovione supply deal for bezuclastinib tabletsPUBT·Sep 2, 2026 at 08:12 PMCOGT-0.32%
$100 Invested In Cogent Biosciences 5 Years Ago Would Be Worth This Much Todaybenzinga_article·Aug 31, 2026 at 10:30 PMCOGT-0.32%
